Loading data for DMIIR — first visit, this takes a few seconds.
Drugs Made In America Acq... (DMIIR)
NasdaqGM: DMIIR
· Real-Time Price · USD
0.10
+0.00 (0.00%)
At close: Aug 17, 2026, 8:00 PM
Drugs Made In America Acquisition II Corp. (DMIIR) Stock Price, Analysis & Data
0.00% (1D)
No data available
| Bid | n/a |
| Market Cap | n/a |
| Revenue (ttm) | n/a |
| Net Income (ttm) | 8.58M |
| Beta | n/a |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| P/B (ttm) | -0.36 |
| P/S (ttm) | n/a |
| Earnings Date | n/a |
| Ask | n/a |
| Volume | 83 |
| Avg. Volume (20D) | |
| Open | 0.09 |
| Previous Close | 0.10 |
| Day's Range | 0.10 - 0.10 |
| 52-Week Range | 0.10 - 0.10 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About DMIIR
Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York...
Full Company ProfileFinancial Performance
In undefined, Drugs Made In America Acquisition II's revenue was n/a, an increase of undefined% compared to the previous year's n/a. Earnings were n/a, an increase of undefined%.
Financial Statements
